Pre-Open Stock Movers:

Greenland Technologies Holding Corporation (NASDAQ: GTEC) 212% HIGHER; The company and Fujian South China Heavy Machinery Manufacture Co. Ltd., a leading company specialized in designing, manufacturing and distributing heavy industrial machinery and vehicles, today announced a co-operation agreement to utilize SOCMA's existing supply-chain and certain technologies to support Greenland's production of electric industrial vehicles in the United States. The agreement also represents a commitment by Greenland to invest in the U.S. as a key center of innovation in the global electric vehicle market.

Immunome, Inc. (Nasdaq: IMNM) 202% HIGHER; announced today that its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant (B.1.351), in pseudovirus testing.

QuickLogic Corporation (NASDAQ: QUIK) 53% HIGHER; announced it has released an Amazon-qualified reference design that empowers OEMs and ODMs to evaluate and develop their own smart hearable products quickly and easily.

Osprey Technology Acquisition Corp. (NYSE: SFTW) 26% HIGHER; BlackSky Holdings, Inc., a leading provider of real-time geospatial intelligence and global monitoring services, and Osprey Technology Acquisition Corp. (NYSE: SFTW), a special purpose acquisition company, today announced they have entered into a definitive agreement for a business combination that would result in BlackSky becoming a publicly listed company. It is anticipated that the post-closing company, BlackSky will be listed on the NYSE with the ticker symbol “BKSY”.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) 18% HIGHER; Eli Lilly and Company (NYSE: LLY) and Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications including autoimmune and inflammatory diseases. Pursuant to the collaboration, Lilly will also lead all clinical development of brain penetrating RIPK1 inhibitors in central nervous system (CNS) diseases.

iMedia Brands, Inc. (NASDAQ: IMBI) 16.4% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

VistaGen Therapeuticsen Therapeutics (NASDAQ: VTGN) 15% HIGHER; Jefferies initiates coverage on with a Buy rating and a price target of $6.00.

Altitude Acquisition Corp. (NASDAQ: ALTU) 14.7% HIGHER; Aerion is in talks to go public through a merger with Altitude Acquisition Corp. (NASDAQ: ALTU), according to Bloomberg, citing sources.

Sleep Number Corporation (NASDAQ: SNBR) 12.6% HIGHER; reported Q4 EPS of $2.19, $0.75 better than the analyst estimate of $1.44. Revenue for the quarter came in at $568 million versus the consensus estimate of $551.5 million. Sleep Number Corporation sees FY2021 EPS of at least $6.00, versus the consensus of $4.48.

Tilray, Inc. (NASDAQ: TLRY) 11% HIGHER; reported Q4 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $56.6 million versus the consensus estimate of $55.76 million.

Workiva Inc. (NYSE: WK) 11% HIGHER; announced that Stuart Miller will retire as Executive Vice President and Chief Financial Officer after serving in the role for the past seven years. Jill Klindt, Workivas Senior Vice President, Treasurer and Chief Accounting Officer, has been named Chief Financial Officer, effective Feb. 27, 2021.

Mantech Int'l (NASDAQ: MANT) 10.2% HIGHER; reported Q4 EPS of $0.79, in-line with the analyst estimate of $0.79. Revenue for the quarter came in at $638.8 million versus the consensus estimate of $628.57 million. Mantech Int'l sees FY2021 EPS of $3.48-$3.60, versus the consensus of $3.49. Mantech Int'l sees FY2021 revenue of $2.65-2.75 billion, versus the consensus of $2.66 billion.

Twilio (NYSE: TWLO) 9.6% HIGHER; reported Q4 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $548.1 million versus the consensus estimate of $454.75 million. Twilio sees Q1 2021 EPS of ($0.12)-($0.09), versus the consensus of ($0.02). Twilio sees Q1 2021 revenue of $526-536 million, versus the consensus of $492.08 million.

Brightcove (NASDAQ: BCOV) 9.3% HIGHER; reported Q4 EPS of $0.14, $0.08 better than the analyst estimate of $0.06. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $49.79 million. Brightcove sees Q1 2021 EPS of $0.09-$0.11, versus the consensus of $0.08. Brightcove sees Q1 2021 revenue of $53-54 million, versus the consensus of $50.44 million. Brightcove sees FY2021 EPS of $0.44-$0.56, versus the consensus of $0.38. Brightcove sees FY2021 revenue of $211-217 million, versus the consensus of $212.44 million.

AMC Entertainment (NYSE: AMC) 9% HIGHER; unconfirmed rumors of a takeover by Amazon (NASDAQ: AMZN) via Forbes.

Stamps.com (NASDAQ: STMP) 8.8% LOWER; reported Q4 EPS of $4.13, $1.51 better than the analyst estimate of $2.62. Revenue for the quarter came in at $206 million versus the consensus estimate of $194.26 million.

Fastly, Inc. (NYSE: FSLY) 7.2% LOWER; reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $83 million versus the consensus estimate of $82.03 million. Fastly, Inc. sees Q1 2021 revenue of $83-86 million, versus the consensus of $84.6 million. Fastly, Inc. sees FY2021 revenue of $375-385 million, versus the consensus of $379.5 million.

SunPower (NASDAQ: SPWR) 6% LOWER; reported Q4 EPS of $0.14, $0.07 better than the analyst estimate of $0.07. Revenue for the quarter came in at $341.8 million versus the consensus estimate of $355.84 million.

Community Health Systems (NYSE: CYH) 5.8% HIGHER; reported Q4 EPS of $0.96, $0.76 better than the analyst estimate of $0.20. Revenue for the quarter came in at $3.12 billion versus the consensus estimate of $3.07 billion.

iQIYI (NASDAQ: IQ) 5.3% LOWER; reported Q4 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.16 billion.

Veru Inc. (NASDAQ: VERU) 4.3% LOWER; intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering.